These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2493480)

  • 1. Effect of intranasal growth hormone-releasing hormone and corticotropin-releasing hormone administration on growth hormone and cortisol release: improved bioavailability by means of sodium-glycocholate.
    Pontiroli AE; Perfetti MG; Fattor B; Pozza G
    J Clin Endocrinol Metab; 1989 Apr; 68(4):821-4. PubMed ID: 2493480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man.
    Barbarino A; Corsello SM; Della Casa S; Tofani A; Sciuto R; Rota CA; Bollanti L; Barini A
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1368-74. PubMed ID: 2229294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intravenous, subcutaneous, and intranasal administration of growth hormone (GH)-releasing hormone-40 on serum GH concentrations in normal men.
    Evans WS; Vance ML; Kaiser DL; Sellers RP; Borges JL; Downs TR; Frohman LA; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1985 Nov; 61(5):846-50. PubMed ID: 3930551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent inhibition of growth hormone (GH)-releasing hormone-induced GH release by corticotropin-releasing hormone in prepubertal children.
    Ghizzoni L; Vottero A; Street ME; Bernasconi S
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1397-400. PubMed ID: 8636340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct effects of corticotrophin-releasing hormone on stimulated growth hormone secretion.
    Raza J; Massoud AF; Hindmarsh PC; Robinson IC; Brook CG
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):217-22. PubMed ID: 9579235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ghrelin alone or co-administered with GHRH or CRH increases non-REM sleep and decreases REM sleep in young males.
    Kluge M; Schüssler P; Bleninger P; Kleyer S; Uhr M; Weikel JC; Yassouridis A; Zuber V; Steiger A
    Psychoneuroendocrinology; 2008 May; 33(4):497-506. PubMed ID: 18329818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal relationship between the level of circulating cortisol and growth hormone secretion in response to growth hormone-releasing hormone in man: studies in patients with adrenal insufficiency.
    Giustina A; Bresciani E; Bossoni S; Chiesa L; Misitano V; Wehrenberg WB; Veldhuis JD
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1266-72. PubMed ID: 7962318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunological determination of exogenous corticotropin-releasing hormone (CRH) and growth hormone-releasing hormone (GHRH): plasma half-life of CRH and GHRH.
    Soszyński P; Jeske W; Rogoziński W; Zgliczyński S
    Endokrynol Pol; 1989; 40(5):227-33. PubMed ID: 2518275
    [No Abstract]   [Full Text] [Related]  

  • 9. Growth hormone-releasing hormone and corticotropin-releasing hormone enhance non-rapid-eye-movement sleep after sleep deprivation.
    Schüssler P; Yassouridis A; Uhr M; Kluge M; Weikel J; Holsboer F; Steiger A
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E549-56. PubMed ID: 16912060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone-releasing hormone facilitates hypoglycemia-induced release of cortisol.
    Perras B; Schultes B; Schwaiger R; Metz C; Wesseler W; Born J; Fehm HL
    Regul Pept; 2002 Dec; 110(1):85-91. PubMed ID: 12468113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid sequential intravenous administration of four hypothalamic releasing hormones as a combined anterior pituitary function test in normal subjects.
    Sheldon WR; DeBold CR; Evans WS; DeCherney GS; Jackson RV; Island DP; Thorner MO; Orth DN
    J Clin Endocrinol Metab; 1985 Apr; 60(4):623-30. PubMed ID: 2982903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyporesponsiveness of the pituitary to CRH during slow wave sleep is not mimicked by systemic GHRH.
    Antonijevic IA; Murck H; Frieboes R; Holsboer TT; Steiger A
    Neuroendocrinology; 1999 Feb; 69(2):88-96. PubMed ID: 9986921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of a combined anterior pituitary function test in beagle dogs: rapid sequential intravenous administration of four hypothalamic releasing hormones.
    Meij BP; Mol JA; Hazewinkel HA; Bevers MM; Rijnberk A
    Domest Anim Endocrinol; 1996 Mar; 13(2):161-70. PubMed ID: 8665804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repetitive injections of growth hormone releasing hormone (GHRH1-44) to normal volunteers and patients with growth hormone deficiency.
    Hümmelink R; Sippell WG
    Horm Metab Res; 1990 Feb; 22(2):101-8. PubMed ID: 2182500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
    Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man.
    Giustina A; Girelli A; Doga M; Bodini C; Bossoni S; Romanelli G; Wehrenberg WB
    J Clin Endocrinol Metab; 1990 Sep; 71(3):580-4. PubMed ID: 2118535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of chronic administration of the serotonin agonist dexfenfluramine on responsiveness to corticotropin releasing hormone and growth hormone-releasing hormone in moderately obese people.
    Drent ML; Adèr HJ; van der Veen EA
    J Endocrinol Invest; 1995 Nov; 18(10):780-8. PubMed ID: 8787955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of corticotropin and growth hormone releasing hormones on their respective secretory axes in chronic hemodialysis patients before and after correction of anemia with recombinant human erythropoietin.
    Ramirez G; Bittle PA; Sanders H; Rabb HA; Bercu BB
    J Clin Endocrinol Metab; 1994 Jan; 78(1):63-9. PubMed ID: 8288716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects.
    Aloi JA; Gertz BJ; Hartman ML; Huhn WC; Pezzoli SS; Wittreich JM; Krupa DA; Thorner MO
    J Clin Endocrinol Metab; 1994 Oct; 79(4):943-9. PubMed ID: 7962302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of subcutaneous and intranasal administration of ovine corticotropin-releasing hormone in man: comparison with intravenous administration.
    DeBold CR; Sheldon WR; DeCherney GS; Jackson RV; Nicholson WE; Island DP; Orth DN
    J Clin Endocrinol Metab; 1985 May; 60(5):836-40. PubMed ID: 2984233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.